FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...